Andre Ignacio

Andre Ignacio serves as CEO at Samtec Biotecnologia Ltda. Samtec Biotecnologia Ltda operates in the pharmaceuticals sector with approximately 98.0 employees. The company is headquartered in Ribeirao Preto, Sao Paulo.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 558 executive contacts are available in Sao Paulo.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook CloudFlare Hosting Google translate widget Google Font API Mobile Friendly Django Google translate API Render AI

pharmaceutical manufacturing injectable medicines hospital solutions saline solution sodium bicarbonate potassium chloride sodium chloride glucose solution magnesium sulfate medical products parenteral solutions biotechnology drug manufacturing quality assurance patient safety medical equipment automated processes industrial excellence product validation hands-on training research & development community responsibility sustainable practices regulatory compliance life sciences healthcare solutions patient care safety protocols operational excellence industry leadership pharmaceutical technology low-volume solutions injectable solutions innovation inventory management healthcare delivery medical research quality management systems controlled environment automated production training programs customer service medical professionals technical documentation distribution network drug efficacy performance metrics cross-disciplinary teamwork product lifecycle market presence pharmaceuticals medical

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Andre Ignacio in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Samtec Biotecnologia Ltda.

Andre Ignacio's Position in the MessageCEO Database

• •Andre Ignacio is 1 of 1 verified executive contact we track at Samtec Biotecnologia Ltda.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •557 verified executive contacts in Sao Paulo are in the database.
• •4 verified contacts work at pharmaceuticals companies in the 98.0 employee range (same size as Samtec Biotecnologia Ltda).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Andre Ignacio directly?

Andre Ignacio's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Samtec Biotecnologia Ltda. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Andre Ignacio work for?

Andre Ignacio is CEO at Samtec Biotecnologia Ltda, a company in the pharmaceuticals sector with 98.0 employees. The company is based in Ribeirao Preto, Sao Paulo.

Can I pitch or sell to Andre Ignacio?

As CEO at Samtec Biotecnologia Ltda, Andre Ignacio is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Andre Ignacio directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Andre Ignacio in?

Andre Ignacio works in the pharmaceuticals industry as CEO at Samtec Biotecnologia Ltda. MessageCEO provides verified contact information for executives across all major industries.

Is Andre Ignacio's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Andre Ignacio's profile is kept up-to-date with the latest available information.

Last updated: July 22, 2026